STANDARD BIOTLS (LAB)
(Delayed Data from NSDQ)
$2.10 USD
+0.11 (5.53%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $2.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/26/2025
Time: -- |
12/2024 | $-0.07 | 0.00% |
Earnings Summary
For their last quarter, STANDARD BIOTLS (LAB) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.08 per share. This reflects a positive earnings surprise of 37.50%. Look out for LAB's next earnings release expected on February 26, 2025. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year increase of 12.5%.
Earnings History
Price & Consensus
Zacks News for LAB
Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates
LAB: What are Zacks experts saying now?
Zacks Private Portfolio Services